section name header

Pronunciation

ser-ta-KON-a-zole

Classifications

Therapeutic Classification: antifungals

Pharmacologic Classification: imidazoles

Indications

REMS


Action

  • Inhibits synthesis of ergosterol, a component of fungal cell membrane, resulting in cytoplasmic leakage and fungal cell death.
Therapeutic effects:
  • Resolution of fungal infection.

Spectrum:

Pharmacokinetics

Absorption: Minimal systemic absorption.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile

ROUTEONSETPEAKDURATION
topwithin 2 wkunknownunknown





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: application site reactions, burning, contact dermatitis, dry skin, tenderness

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Ertaczo